Investor Relations

We are a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders. We improve compliance, absorption, and more with our proprietary drug delivery technology.

Key Ratios

Price & Volume
Recent Price$0.89
52 Week High$2.42
52 Week Low$0.85
Average Volume (30 days)519.19K
Share Related Items
Market Cap$78.68M
Shares Outstanding88.29M
Dividend Information
Yield %--
Annual Dividend--
Payout Ratio-263.2%
Financial Strength
Quick Ratio (MRQ)6.0
Current Ratio (MRQ)6.3
LT Debt/Capital (MRQ)3%
Total Debt/Equity (MRQ)10%
Valuation Ratios
Price/Earnings (TTM)(4.20)
Price/Sales (TTM)1,430.63
Price/Book (MRQ)2.40
Price/Cash Flow (TTM)--
Per Share Data
Earnings (TTM)($0.21)
Sales (TTM)$0.00
Book Value (MRQ)$0.37
Cash Flow (TTM)($0.21)
Cash (MRQ)$0.44
Management Effectiveness
Return on Equity (TTM)-75.1%
Return on Assets (TTM)-54.6%
Return on Investment (TTM)-65.7%
Gross Margin (TTM)-14,250.0%
EBIT Margin (TTM)-31,852.8%
Profit Margin (TTM)--